Patricia Carr, an SVP, chief accounting officer at Jazz Pharmaceuticals plc, sells $326,910 of stock
The sale reduces the insider's holding by 18%, the filing shows.
Patricia Carr, an SVP, chief accounting officer of Jazz Pharmaceuticals plc (JAZZ), sold 1,413 shares on Nov 4 at an average price of $231.36, a total of about $330,000, according to a Form 4 filed with the SEC on Nov 6.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. After the trade, the filing lists 6,512 shares held.
The trade was reported within two business days, as Section 16 requires.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Jazz Pharmaceuticals plc (JAZZ) |
|---|---|
| Insider | Patricia Carr |
| Role | SVP, Chief Accounting Officer |
| Transaction | Open-market sale (code S) |
| Shares | 1,413 |
| Average price | $231.36 |
| Value | $326,910 |
| Trade date | Nov 4, 2026 |
| Filed with the SEC | Nov 6, 2026, 5:19 PM ET |
| Shares held after | 6,512 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See every transaction in this Jazz Pharmaceuticals plc filing
Follow JAZZ for the next insider trade · See all the latest insider trades
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
